跳转至内容
Merck
CN

E7770

乙酸乙酯

ACS reagent, ≥99.5%

别名:

EtOAc

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:
CH3COOC2H5
化学文摘社编号:
分子量:
88.11
EC Number:
205-500-4
UNSPSC Code:
12352103
MDL number:
Beilstein/REAXYS Number:
506104
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


grade

ACS reagent

vapor density

3 (20 °C, vs air)

vapor pressure

73 mmHg ( 20 °C)

assay

≥99.5%

autoignition temp.

801 °F

expl. lim.

2.2-11.5 %, 38 °F

impurities

Substances darkened by sulfuric acid, passes test, ≤0.0009 meq/g Titratable acid, ≤0.2% Water (H2O)

evapn. residue

≤0.003%

color

APHA: ≤10

refractive index

n20/D 1.3720 (lit.)

bp

76.5-77.5 °C (lit.)

mp

−84 °C (lit.)

density

0.902 g/mL at 25 °C (lit.)

SMILES string

CCOC(C)=O

InChI

1S/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H3

InChI key

XEKOWRVHYACXOJ-UHFFFAOYSA-N



Still not finding the right product?

Explore all of our products under 乙酸乙酯


pictograms

FlameExclamation mark

signalword

Danger

Hazard Classifications

Eye Irrit. 2 - Flam. Liq. 2 - STOT SE 3

target_organs

Central nervous system

supp_hazards

存储类别

3 - Flammable liquids

wgk

WGK 1

flash_point_f

24.8 °F - closed cup

flash_point_c

-4 °C - closed cup

ppe

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter

法规信息

新产品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Junwei Liu et al.
Planta, 241(6), 1435-1451 (2015-02-27)
Strigolactone changes and cross talk with ABA unveil a picture of root-specific hormonal dynamics under stress. Strigolactones (SLs) are carotenoid-derived hormones influencing diverse aspects of development and communication with (micro)organisms, and proposed as mediators of environmental stimuli in resource allocation
K J S Anand et al.
British journal of anaesthesia, 101(5), 680-689 (2008-08-30)
Relationships between plasma morphine concentrations and neonatal responses to endotracheal tube (ETT) suctioning are unknown in preterm neonates. Ventilated preterm neonates (n=898) from 16 centres were randomly assigned to placebo (n=449) or morphine (n=449). After an i.v. loading dose (100
Yuusuke Fujimoto et al.
PloS one, 7(11), e48685-e48685 (2012-11-13)
Combination therapy with ribavirin, interferon, and viral protease inhibitors could be expected to elicit a high level of sustained virologic response in patients infected with hepatitis C virus (HCV). However, several severe side effects of this combination therapy have been